BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24323439)

  • 1. Brain and liver iron accumulation in aceruloplasminemia.
    Fujita K; Osaki Y; Harada M; Kono S; Miyajima H; Izumi Y; Kaji R
    Neurology; 2013 Dec; 81(24):2145-6. PubMed ID: 24323439
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurodegeneration With Brain Iron Accumulation: A Novel Mutation in the Ceruloplasmin Gene.
    Stelten BML; van Ommen W; Keizer K
    JAMA Neurol; 2019 Feb; 76(2):229-230. PubMed ID: 30383083
    [No Abstract]   [Full Text] [Related]  

  • 3. Never forget aceruloplasminemia in case of highly suggestive Wilson's disease score.
    Kerkhof M; Honkoop P
    Hepatology; 2014 Apr; 59(4):1645-7. PubMed ID: 24002824
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of iron in neurodegenerative disorders.
    Berg D; Youdim MB
    Top Magn Reson Imaging; 2006 Feb; 17(1):5-17. PubMed ID: 17179893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teaching NeuroImages: neurodegeneration with brain iron accumulation in aceruloplasminemia.
    Parks NE; Vandorpe RA; Moeller JJ
    Neurology; 2013 Nov; 81(20):e151-2. PubMed ID: 24218322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aceruloplasminemia.
    Miyajima H
    Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
    Rusticeanu M; Zimmer V; Schleithoff L; Wonney K; Viera J; Zimmer A; Hübschen U; Bohle RM; Grünhage F; Lammert F
    Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349
    [No Abstract]   [Full Text] [Related]  

  • 8. Aceruloplasminemia in a Turkish adolescent with a novel mutation of ceruloplasmin gene: the first diagnosed case from Turkey.
    Meral Gunes A; Sezgin Evim M; Baytan B; Iwata A; Hida A; Avci R
    J Pediatr Hematol Oncol; 2014 Oct; 36(7):e423-5. PubMed ID: 25247888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.
    Zanardi A; Conti A; Cremonesi M; D'Adamo P; Gilberti E; Apostoli P; Cannistraci CV; Piperno A; David S; Alessio M
    EMBO Mol Med; 2018 Jan; 10(1):91-106. PubMed ID: 29183916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.
    Finkenstedt A; Wolf E; Höfner E; Gasser BI; Bösch S; Bakry R; Creus M; Kremser C; Schocke M; Theurl M; Moser P; Schranz M; Bonn G; Poewe W; Vogel W; Janecke AR; Zoller H
    J Hepatol; 2010 Dec; 53(6):1101-7. PubMed ID: 20801540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron chelation therapy to prevent the manifestations of aceruloplasminemia.
    Bove F; Fasano A
    Neurology; 2015 Sep; 85(12):1085-6. PubMed ID: 26311749
    [No Abstract]   [Full Text] [Related]  

  • 12. MR imaging for the quantitative assessment of brain iron in aceruloplasminemia: A postmortem validation study.
    Vroegindeweij LHP; Wielopolski PA; Boon AJW; Wilson JHP; Verdijk RM; Zheng S; Bonnet S; Bossoni L; van der Weerd L; Hernandez-Tamames JA; Langendonk JG
    Neuroimage; 2021 Dec; 245():118752. PubMed ID: 34823024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aceruloplasminemia: An entity to consider in patients with anemia.
    Lozano-Varela M; Carrera-Alonso E; Plaza-Palacios G
    Rev Esp Enferm Dig; 2014 May; 106(5):360-1. PubMed ID: 25287242
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurodegeneration with brain iron accumulation.
    McNeill A; Chinnery PF
    Handb Clin Neurol; 2011; 100():161-72. PubMed ID: 21496576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aceruloplasminemia: an update.
    Kono S
    Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aceruloplasminemia: Neurodegeneration with brain iron accumulation associated with psychosis.
    Vroegindeweij LHP; Boon AJW; Wilson JHP; Langendonk JG
    J Inherit Metab Dis; 2019 Mar; 42(2):195-196. PubMed ID: 30671987
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aceruloplasminemia, a rare condition not to be overlooked].
    Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S
    Rev Med Interne; 2020 Nov; 41(11):769-775. PubMed ID: 32682623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of desferrioxamine in the treatment of aceruloplasminemia.
    Miyajima H; Takahashi Y; Kamata T; Shimizu H; Sakai N; Gitlin JD
    Ann Neurol; 1997 Mar; 41(3):404-7. PubMed ID: 9066364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of Copper in the Iron-Rich Particles of Aceruloplasminemia Brain.
    Yoshida K; Hayashi H; Wakusawa S; Shigemasa R; Koide R; Ishikawa T; Tatsumi Y; Kato K; Ohara S; Ikeda SI
    Biol Trace Elem Res; 2017 Jan; 175(1):79-86. PubMed ID: 27272717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system involvement in a rare genetic iron overload disorder.
    Bethlehem C; van Harten B; Hoogendoorn M
    Neth J Med; 2010 Oct; 68(10):316-8. PubMed ID: 21071777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.